{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:37:35Z","timestamp":1790314655630,"version":"4.1.0"},"publisher-location":"Berlin\/Heidelberg","reference-count":59,"publisher":"Springer-Verlag","isbn-type":[{"value":"3540222286","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-26980-0_3","type":"book-chapter","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T16:39:31Z","timestamp":1136479171000},"page":"35-46","source":"Crossref","is-referenced-by-count":15,"title":["Genetics and Prevention of Oesophageal Adenocarcinoma"],"prefix":"10.1007","author":[{"given":"Rebecca C.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"S.H. Landis","year":"1999","unstructured":"Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8\u201331","journal-title":"CA Cancer J Clin"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","volume":"83","author":"S.S. Devesa","year":"1998","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049\u20132053","journal-title":"Cancer"},{"key":"3_CR3","unstructured":"Berrino F, Capocaccia R, Esteve J, et al (1999) Survival of cancer patients in Europe\u2014 the EUROCARE-2 study. International Agency for Research on Cancer (IARC), vol. 151"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrc1166","volume":"3","author":"C.P. Wild","year":"2003","unstructured":"Wild CP, Hardie LJ (2003) Reflux, Barrett\u2019s oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676\u2013684","journal-title":"Nat Rev Cancer"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2036.2001.01046.x","volume":"15","author":"R.F. Souza","year":"2001","unstructured":"Souza RF, Morales CP, Spechler SJ (2001) A conceptual approach to understanding the molecular mechanisms of cancer development in Barrett\u2019s oesophagus. Aliment Pharmacol Ther 15:1087\u20131100","journal-title":"Aliment Pharmacol Ther"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1052-5157(03)00005-9","volume":"13","author":"M. Guindi","year":"2003","unstructured":"Guindi M, Riddell RH (2003) Histology of Barrett\u2019s esophagus and dysplasia. Gastrointest Endosc Clin N Am 13:349\u2013368, viii","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J. Lagergren","year":"1999","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for oesophageal adenocarcinoma. N Engl J Med 340:825\u2013832","journal-title":"N Engl J Med"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/0016-5085(90)90607-3","volume":"99","author":"A.J. Cameron","year":"1990","unstructured":"Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA (1990) Prevalence of columnarlined (Barrett\u2019s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99:1918\u20131922","journal-title":"Gastroenterology"},{"key":"3_CR9","first-page":"A82","volume":"112","author":"A. Cameron","year":"1997","unstructured":"Cameron A, Kamath P, Carpenter H (1997) Prevalence of Barrett\u2019s esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology 112:A82","journal-title":"Gastroenterology"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/gast.2000.9302","volume":"119","author":"N.J. Shaheen","year":"2000","unstructured":"Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS (2000) Is there publication bias in the reporting of cancer risk in Barrett\u2019s esophagus? Gastroenterology 119:333\u2013338","journal-title":"Gastroenterology"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/j.1572-0241.2003.07666.x","volume":"98","author":"M. Conio","year":"2003","unstructured":"Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D\u2019Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macri G, Fiocca R, Munizzi F, Filiberti R (2003) Long-term endoscopic surveillance of patients with Barrett\u2019s esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 98:1931\u20131939","journal-title":"Am J Gastroenterol"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bmj.327.7414.534","volume":"327","author":"L. Murray","year":"2003","unstructured":"Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A (2003) Risk of adeno carcinoma in Barrett\u2019s oesophagus: population based study. Br Med J 327:534\u2013535","journal-title":"Br Med J"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1365-2036.2003.01586.x","volume":"15","author":"A. Mandal","year":"2003","unstructured":"Mandal A, Playford R, Wicks A (2003) Current practice in surveillance strategy for patients with Barrett\u2019s oesophagus in the UK. Aliment Pharmacol Ther 15:1319\u20131324","journal-title":"Aliment Pharmacol Ther"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1572-0241.2002.05910.x","volume":"97","author":"R.E. Sampliner","year":"2002","unstructured":"Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett\u2019s esophagus. Am J Gastroenterol 97:1888\u20131895","journal-title":"Am J Gastroenterol"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0002-9343(01)00745-8","volume":"111","author":"V.F. Eckardt","year":"2001","unstructured":"Eckardt VF, Kanzler G, Bernhard G (2001) Life expectancy and cancer risk in patients with Barrett\u2019s esophagus: a prospective controlled investigation. Am J Med 111:33\u201337","journal-title":"Am J Med"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bmj.321.7271.1252","volume":"321","author":"C.E. Macdonald","year":"2000","unstructured":"Macdonald CE, Wicks AC, Playford RJ (2000) Final results from 10 year cohort of patients undergoing surveillance for Barrett\u2019s oesophagus: observational study. BMJ 321:1252\u20131255","journal-title":"BMJ"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/gast.2002.31879","volume":"122","author":"D.A. Corley","year":"2002","unstructured":"Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA (2002) Surveillance and survival in Barrett\u2019s adenocarcinomas: a population-based study. Gastroenterology 122:633\u2013640","journal-title":"Gastroenterology"},{"key":"3_CR18","first-page":"1293","volume":"92","author":"D. Lieberman","year":"1997","unstructured":"Lieberman D, Oehlke M, Helfand M (1997) Risk factors for Barrett\u2019s eosphagus in community-based practice, GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 92:1293\u20131297","journal-title":"Am J Gastroenterol"},{"issue":"Suppl1","key":"3_CR19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0953-0673.2004.01838.x","volume":"19","author":"S.J. Spechler","year":"2004","unstructured":"Spechler SJ, Barr H (2004) Screening and surveillance of Barrett\u2019s oesophagus: what is a cost-effective framework? Aliment Pharmacol Ther 19 Suppl 1:49\u201353","journal-title":"Aliment Pharmacol Ther"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/j.1572-0241.2001.03933.x","volume":"96","author":"L.B. Gerson","year":"2001","unstructured":"Gerson LB, Edson R, Lavori PW, Triadafilopoulos G (2001) Use of a simple symptom questionnaire to predict Barrett\u2019s esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 96:2005\u20132012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0016-5107(03)02011-X","volume":"58","author":"G.R. Locke","year":"2003","unstructured":"Locke GR, Zinsmeister AR, Talley NJ (2003) Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 58(5):661\u2013670","journal-title":"Gastrointest Endosc"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/gast.2002.34748","volume":"123","author":"L.B. Gerson","year":"2002","unstructured":"Gerson LB, Shetler K, Triadafilopoulos G (2002) Prevalence of Barrett\u2019s esophagus in asymptomatic individuals. Gastroenterology 123:461\u2013467","journal-title":"Gastroenterology"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2003.09.030","volume":"125","author":"D.K. Rex","year":"2003","unstructured":"Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ (2003) Screening for Barrett\u2019s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125:1670\u20131677","journal-title":"Gastroenterology"},{"issue":"5","key":"3_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1572-0241.1999.01127.x","volume":"94","author":"Y. Romero","year":"1999","unstructured":"Romero Y, Locke GR 3rd (1999) Is there a GERD gene? Am J Gastroenterol 94(5):1127\u20131129","journal-title":"Am J Gastroenterol"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jmg.40.9.651","volume":"40","author":"C.M. Drovdlic","year":"2003","unstructured":"Drovdlic CM, Goddard KA, Chak A, Brock W, Chessler L, King JF, Richter J, Falk GW, Johnston DK, Fisher JL, Grady WM, Lemeshow S, Eng C (2003) Demographic and phenotypic features of 70 families segregating Barrett\u2019s oesophagus and oesophageal adenocarcinoma. J Med Genet 40:651\u2013656","journal-title":"J Med Genet"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/gast.1997.v113.pm9352846","volume":"113","author":"Y. Romero","year":"1997","unstructured":"Romero Y, Cameron AJ, Locke GR 3rd, Schaid DJ, Slezak JM, Branch CD, Melton LJ 3rd (1997) Familial aggregation of gastroesophageal reflux in patients with Barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterology 113:1449\u20131456","journal-title":"Gastroenterology"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/gast.2002.30301","volume":"122","author":"A.J. Cameron","year":"2002","unstructured":"Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR 3rd, Pedersen NL (2002) Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 122:55\u201359","journal-title":"Gastroenterology"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jama.284.3.325","volume":"284","author":"F.Z. Hu","year":"2000","unstructured":"Hu FZ, Preston RA, Post JC, White GJ, Kikuchi LW, Wang X, Leal SM, Levenstien MA, Ott J, Self TW, Allen G, Stiffler RS, McGraw C, Pulsifer-Anderson EA, Ehrlich GD (2000) Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14. Jama 284:325\u2013334","journal-title":"Jama"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1023\/A:1024715824149","volume":"48","author":"D.V. Gopal","year":"2003","unstructured":"Gopal DV, Lieberman DA, Magaret N, Fennerty MB, Sampliner RE, Garewal HS, Falk GW, Faigel DO (2003) Risk factors for dysplasia in patients with Barrett\u2019s esophagus (BE): results from a multicenter consortium. Dig Dis Sci 48:1537\u20131541","journal-title":"Dig Dis Sci"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1440-1746.2003.02965.x","volume":"18","author":"L.C. Hillman","year":"2003","unstructured":"Hillman LC, Chiragakis L, Clarke AC, Kaushik SP, Kaye GL (2003) Barrett\u2019s esophagus: macroscopic markers and the prediction of dysplasia and adenocarcinoma. J Gastroenterol Hepatol 18:526\u2013533","journal-title":"J Gastroenterol Hepatol"},{"key":"3_CR31","first-page":"4211","volume":"63","author":"M.T. Barrett","year":"2003","unstructured":"Barrett MT, Pritchard D, Palanca-Wessels C, Anderson J, Reid BJ, Rabinovitch PS (2003) Molecular phenotype of spontaneously arising 4 N (G2-tetraploid) intermediates of neoplastic progression in Barrett\u2019s esophagus. Cancer Res 63:4211\u20134217","journal-title":"Cancer Res"},{"key":"3_CR32","first-page":"4784","volume":"59","author":"L.J. Prevo","year":"1999","unstructured":"Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ (1999) p53-mutant clones and field effects in Barrett\u2019s esophagus. Cancer Res 59:4784\u20134787","journal-title":"Cancer Res"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1101\/gr.9.5.482","volume":"9","author":"T.G. Paulson","year":"1999","unstructured":"Paulson TG, Galipeau PC, Reid BJ (1999) Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res 9:482\u2013492","journal-title":"Genome Res"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","volume":"96","author":"B.J. Reid","year":"2001","unstructured":"Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS, Blount PL, Rabinovitch PS (2001) Predictors of progression in Barrett\u2019s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96:2839\u20132848","journal-title":"Am J Gastroenterol"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1442-2050.2003.00302.x","volume":"16","author":"K. Dolan","year":"2003","unstructured":"Dolan K, Walker SJ, Gosney J, Field JK, Sutton R (2003) TP53 mutations in malignant and premalignant Barrett\u2019s esophagus. Dis Esophagus 16:83\u201389","journal-title":"Dis Esophagus"},{"key":"3_CR36","first-page":"1669","volume":"95","author":"B.J. Reid","year":"2000","unstructured":"Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS (2000) Predictors of progression to cancer in Barrett\u2019s esophagus: baseline histology and flow cytometry identify low-and high-risk patient subsets. Am J Gastroenterol 95:1669\u20131676","journal-title":"Am J Gastroenterol"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/S0046-8177(03)00354-X","volume":"34","author":"S. Iravani","year":"2003","unstructured":"Iravani S, Zhang HQ, Yuan ZQ, Cheng JQ, Karl RC, Jove R, Coppola D (2003) Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett\u2019s neoplasia. Hum Pathol 34:975\u2013982","journal-title":"Hum Pathol"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/8816","volume":"22","author":"M.T. Barrett","year":"1999","unstructured":"Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22:106\u2013109","journal-title":"Nat Genet"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.onc.1205111","volume":"21","author":"F.M. Selaru","year":"2002","unstructured":"Selaru FM, Zou T, Xu Y, Shustova V, Yin J, Mori Y, Sato F, Wang S, Olaru A, Shibata D, Greenwald BD, Krasna MJ, Abraham JM, Meltzer SJ (2002) Global gene expression profiling in Barrett\u2019s esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 21:475\u2013478","journal-title":"Oncogene"},{"key":"3_CR40","first-page":"3493","volume":"62","author":"Y. Xu","year":"2002","unstructured":"Xu Y, Selaru FM, Yin J, Zou TT, Shustova V, Mori Y, Sato F, Liu TC, Olaru A, Wang S, Kimos MC, Perry K, Desai K, Greenwald BD, Krasna MJ, Shibata D, Abraham JM, Meltzer SJ (2002) Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett\u2019s esophagus and esophageal cancer. Cancer Res 62:3493\u20133497","journal-title":"Cancer Res"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1101\/gr.10.8.1126","volume":"10","author":"R. Mei","year":"2000","unstructured":"Mei R, Galipeau PC, Prass C, Berno A, Ghandour G, Patil N, Wolff RK, Chee MS, Reid BJ, Lockhart DJ (2000) Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 10:1126\u20131137","journal-title":"Genome Res"},{"key":"3_CR42","first-page":"2560","volume":"9","author":"P.S. Sirieix","year":"2003","unstructured":"Sirieix PS, O\u2019Donovan M, Brown J, Save V, Coleman N, Fitzgerald RC (2003) Surface expression of mini-chromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett\u2019s oesophagus. Clin Cancer Res 9:2560\u20132566","journal-title":"Clin Cancer Res"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/gut.50.3.373","volume":"50","author":"J.J. Going","year":"2002","unstructured":"Going JJ, Keith WN, Neilson L, Stoeber K, Stuart RC, Williams GH (2002) Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett\u2019s mucosa. Gut 50:373\u2013377","journal-title":"Gut"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1052-5157(03)00016-3","volume":"13","author":"G.W. Falk","year":"2003","unstructured":"Falk GW (2003) Cytology in Barrett\u2019s esophagus. Gastrointest Endosc Clin N Am 13:335\u2013348","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/S0016-5085(03)00393-7","volume":"124","author":"A. Sonnenberg","year":"2003","unstructured":"Sonnenberg A, Fennerty MB (2003) Medical decision analysis of chemoprevention against esophageal adenocarcinoma. Gastroenterology 124:1758\u20131766","journal-title":"Gastroenterology"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/jnci\/95.10.750","volume":"95","author":"R.E. Rudolph","year":"2003","unstructured":"Rudolph RE, Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ (2003) Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett\u2019s esophagus. J Natl Cancer Inst 95:750\u2013757","journal-title":"J Natl Cancer Inst"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc702","volume":"2","author":"A. Schatzkin","year":"2002","unstructured":"Schatzkin A, Gail M (2002) The promise and peril of surrogate end points in cancer research. Nat Rev Cancer 2:19\u201327","journal-title":"Nat Rev Cancer"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1172\/JCI119018","volume":"98","author":"R.C. Fitzgerald","year":"1996","unstructured":"Fitzgerald RC, Omary MB, Triadafilopoulos G (1996) Dynamic effects of acid on Barrett\u2019s esophagus: an ex vivo differentiation and proliferation model. J Clin Invest 98:2120\u20132128","journal-title":"J Clin Invest"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1038\/sj.onc.1204947","volume":"20","author":"M. Umansky","year":"2001","unstructured":"Umansky M, Yasui W, Hallak A, Brill S, Shapira I, Halpern Z, Hibshoosh H, Rattan J, Meltzer S, Tahara E, Arber N (2001) Proton pump inhibitors reduce cell cycle abnormalities in Barrett\u2019s esophagus. Oncogene 20:7987\u20137991","journal-title":"Oncogene"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2036.2001.00939.x","volume":"15","author":"R. Fitzgerald","year":"2001","unstructured":"Fitzgerald R, Traidafilopoulos G (2001) Review article: Barrett\u2019s oesophagus, dysplasia and pharmacologic acid suppression. Aliment Pharmacol Ther 15:269\u2013276","journal-title":"Aliment Pharmacol Ther"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/j.1572-0241.2003.08702.x","volume":"98","author":"K.E. Corey","year":"2003","unstructured":"Corey KE, Schmitz SM, Shaheen NJ (2003) Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett\u2019s esophagus? A metaanalysis. Am J Gastroenterol 98:2390\u20132394","journal-title":"Am J Gastroenterol"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/gast.2003.50091","volume":"124","author":"C.R. Haigh","year":"2003","unstructured":"Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard DM, Varro A, Dimaline R (2003) Gastrin induces proliferation in Barrett\u2019s metaplasia through activation of the CCK2 receptor. Gastroenterology 124:615\u2013625","journal-title":"Gastroenterology"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1053\/j.gastro.2003.05.017","volume":"125","author":"R.C. Fitzgerald","year":"2003","unstructured":"Fitzgerald RC, Abdalla S (2003) Gastrin-induced hyperproliferation in Barrett\u2019s esophagus. Gastroenterology 125:1921; author reply 1921-1922","journal-title":"Gastroenterology"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1053\/gast.2002.32371","volume":"122","author":"N.S. Buttar","year":"2002","unstructured":"Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ (2002) Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett\u2019s esophagus. Gastroenterology 122:1101\u20131112","journal-title":"Gastroenterology"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2559.2003.01627.x","volume":"42","author":"C. Lagorce","year":"2003","unstructured":"Lagorce C, Paraf F, Vidaud D, Couvelard A, Wendum D, Martin A, Flejou JF (2003) Cyclooxygenase-2 is expressed frequently and early in Barrett\u2019s oesophagus and associated adenocarcinoma. Histopathology 42:457\u2013465","journal-title":"Histopathology"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjc.6600820","volume":"88","author":"C. Bosetti","year":"2003","unstructured":"Bosetti C, Talamini R, Franceschi S, Negri E, Garavello W, La Vecchia C (2003) Aspirin use and cancers of the upper aerodigestive tract. Br J Cancer 88:672\u2013674","journal-title":"Br J Cancer"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"D.A. Corley","year":"2003","unstructured":"Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124:47\u201356","journal-title":"Gastroenterology"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1442-2050.2003.00325.x","volume":"16","author":"E.I. Heath","year":"2003","unstructured":"Heath EI, Canto MI, Wu TT, Piantadosi S, Hawk E, Unalp A, Gordon G, Forastiere AA; CBET Research Group (2003) Chemoprevention for Barrett\u2019s esophagus trial. Design and outcome measures. Dis Esophagus 16:177\u2013186","journal-title":"Dis Esophagus"},{"issue":"Suppl1","key":"3_CR59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.0953-0673.2004.01839.x","volume":"19","author":"J. Jankowski","year":"2004","unstructured":"Jankowski J, Sharma P (2004) Approaches to Barrett\u2019s oesophagus treatment-the role of proton pump inhibitors and other interventions. Aliment Pharmacol Ther 19 Suppl 1:54\u201359","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Recent Results in Cancer Research","Tumor Prevention and Genetics III"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-26980-0_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T02:56:45Z","timestamp":1683341805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-26980-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["3540222286"],"references-count":59,"URL":"https:\/\/doi.org\/10.1007\/3-540-26980-0_3","relation":{},"subject":[]}}